In the latest trading session,, 4.69 million Asensus Surgical Inc (AMEX:ASXC) shares changed hands as the company’s beta touched 1.32. With the company’s most recent per share price at $0.34 changing hands around $0.04 or 14.71% at last look, the market valuation stands at $93.58M. ASXC’s current price is a discount, trading about -17.65% off its 52-week high of $0.40. The share price had its 52-week low at $0.17, which suggests the last value was 50.0% up since then. When we look at Asensus Surgical Inc’s average trading volume, we note the 10-day average is 2.18 million shares, with the 3-month average coming to 2.59 million.

Analysts gave the Asensus Surgical Inc (ASXC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ASXC as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Asensus Surgical Inc’s EPS for the current quarter is expected to be -0.05.

Asensus Surgical Inc (AMEX:ASXC) trade information

Instantly ASXC is in green as seen in intraday trades today. With action 7.15%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 7.55%, with the 5-day performance at 7.15% in the green. However, in the 30-day time frame, Asensus Surgical Inc (AMEX:ASXC) is 1.03% up. Looking at the short shares, we see there were 11.29 million shares sold at short interest cover period of 7.11 days.

The consensus price target for the stock as assigned by Wall Street analysts is 1.5, meaning bulls need an upside of 77.33% from its recent market value. According to analyst projections, ASXC’s forecast low is 1.5 with 1.5 as the target high. To hit the forecast high, the stock’s price needs a -341.18% plunge from its current level, while the stock would need to soar -341.18% for it to hit the projected low.

Asensus Surgical Inc (ASXC) estimates and forecasts

Data shows that the Asensus Surgical Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 17.74% over the past 6 months, a 20.00% in annual growth rate that is considerably higher than the industry average of 11.80%. Year-over-year growth is forecast to reach 40.60% up from the last financial year.

Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 3.55M. 2 analysts are of the opinion that Asensus Surgical Inc’s revenue for the current quarter will be 6.12M. The company’s revenue for the corresponding quarters a year ago was 1.09M and 5.43M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 226.00%. The estimates for the next quarter sales put growth at 12.70%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 39.50%. The 2024 estimates are for Asensus Surgical Inc earnings to increase by 20.00%.

ASXC Dividends

Asensus Surgical Inc is expected to release its next quarterly earnings report in September.

Asensus Surgical Inc (AMEX:ASXC)’s Major holders

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 1.3888% or 3.47 million shares worth $0.8 million as of 2024-03-31.

Among Mutual Funds, the top two as of Mar 31, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 7.73 shares estimated at $2.63 million under it, the former controlled 2.83% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.25% of the shares, roughly 3.4 shares worth around $1.16 million.